Close
More
 
back_btn_arrow   Go back
Sign up or login to continue
New to Univadis?
Univadis is a free service for United States Healthcare Professionals.
*Please fill in all required fields.
By clicking "Sign up", I agree to the Terms of Use and Privacy Policy. and attest I am a healthcare professional.
Existing Univadis member:
Sign up or login to continue
Make more time for the moments that matter. Get expertly-curated updates and medical education, instantly.
New to Univadis?
Simply enter a password to join for free, if the information below is correct.
 
*Please enter a valid email address and password.
By clicking "Sign up", I agree to the Terms of Use and Privacy Policy. and attest I am a healthcare professional.
Forgot your password?  Reset now
Existing Univadis member:
Please login to continue
Welcome! Great to have you back.
*Your email address or password is incorrect.
Forgot your password?  Reset now
Reset your password
Please enter your email address, and we will send you a link to reset your password.
*Please enter a valid email address.

is already registered on Univadis

Is this you? Enter your password to continue.
The password you entered is incorrect. Please try again or choose a different option.
Forgot your password?  Reset now
Need more help? Please contact Member Service at support@univadis.com

is already registered on Univadis

Need more help? Please contact Member Service at support@univadis.com
Instructions to create a new password have been sent to the following email address:

For further assistance, please Contact Member Support
Thanks for Registering.
BreadCrumbsIncluded hideAllBreadCrumbs
American Diabetes Association
San Francisco, California, June 7-11, 2019
News Coverage
Essential conference news
CAROLINA results ease concerns about CVD risks with sulfonylureas.
June 18, 2019
CARMELINA and CAROLINA results confirm safe treatment options for T2D.
June 18, 2019
Effects in DECLARE-TIMI 58 trial seen in patients with and without CVD.
June 17, 2019
Drug shows benefit for T2D with high CVD risk in PIONEER 6.
June 17, 2019
CREDENCE finds fewer events in patients with both T2D and kidney disease.
June 17, 2019
Drug could be considered for middle-aged and older patients.
June 17, 2019
2 studies edge the system closer to the clinic.
June 17, 2019
RISE results suggest ominous trajectory for younger patients.
June 13, 2019
Immune therapy appears to delay inevitable diagnosis.
June 13, 2019
RISE study shows no persistent benefit from improved beta-cell function.
June 13, 2019
T2D remission reported in DiRECT.
June 13, 2019
Endoscopic intervention plus liraglutide, lifestyle changes leave 85% with T2D insulin-free.
June 13, 2019
Findings support lower targets in young adults than the ADA recommends.
June 13, 2019
The trio offers improved glucose tolerance, reduced glucose variability vs other interventions.
June 13, 2019
Supplementation offers no protective benefit.
June 13, 2019
Results seen in adults with IGT or untreated newly diagnosed T2D.
June 13, 2019
Weight loss and gain are both linked to increased dementia risk, too.
June 13, 2019
Targets proposed for time-in-range, time-below-range, time-above-range.
June 13, 2019
6+-year delay in T2D onset leads to benefit.
June 13, 2019
Diabetes specialists presented thousands of studies at this year’s ADA meeting. Univadis journalists chose the most clinically relevant ones and summarized them in our easy-to-scan bullet-point format.
Expert Commentary
Jay H. Shubrook, DO
Neil Skolnik, MD
June 13, 2019
4 Comments
Olga T. Gupta, MD
Neil Skolnik, MD
June 13, 2019
Pablo F. Mora, MD, FACE, MsSc, CDE
Neil Skolnik, MD
June 13, 2019
1 Comment, last 10 days ago
Hertzel C. Gerstein, MD, MSc, FRCPC
Neil Skolnik, MD
June 13, 2019
Vanita R. Aroda, MD
Neil Skolnik, MD
June 13, 2019
Vanita R. Aroda, MD
Neil Skolnik, MD
June 13, 2019
3 Comments

Univadis is a free, time-saving medical news & education community designed exclusively for healthcare professionals. Unique executive summaries tame the onslaught of medical literature and keep clinicians up to date in just a few minutes per day. Concise, interactive educational presentations from our experts help clinicians stay on top of practice-changing research and trends, and collaborate with colleagues at any time, on any device.

Aptus Health does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Aptus Health sources.

Copyright © 2019 Aptus Health, Inc. All rights reserved. Version 2.14.509.11

Mobile App

Contact Us

(888) 729-4546
Monday - Friday 8am to 7pm ET

support@univadis.com